Harbor Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Harbor Capital Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$859K	Sell	8,951 -47	-0.5%	-$4.82K	0.06%	397
2026 Q1	$982K	Buy	8,998 +2,775	+45%	+$264K	0.08%	331
2025 Q4	$505K	Sell	6,223 -289	-4%	-$24.9K	0.04%	479
2025 Q3	$570K	Sell	6,512 -15,770	-71%	-$1.41M	0.04%	442
2025 Q2	$1.85M	Buy	22,282 +245	+1%	+$20.5K	0.08%	319
2025 Q1	$1.85M	Sell	22,037 -2,733	-11%	-$254K	0.08%	300
2024 Q4	$2.28M	Buy	24,770 +677	+3%	+$65.1K	0.1%	254
2024 Q3	$2.24M	Buy	24,093 +12,797	+113%	+$1.11M	0.1%	283
2024 Q2	$929K	Buy	11,296 +7,976	+240%	+$586K	0.07%	374
2024 Q1	$220K	Buy	+3,320	New	+$205K	0.03%	581
2023 Q3	–	Sell	-387	Closed	-$26K	–	559
2023 Q2	$26K	Buy	+387	New	+$23.6K	0.01%	555

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Harbor Capital Advisors's LMAT Position: Q2 2026 in Review

Harbor Capital Advisors reduced its LeMaitre Vascular (LMAT) stake by 0.52% in Q2 2026, selling an estimated $4.82K and leaving 8,951 shares worth $859K. The position accounts for 0.06% of the portfolio, ranked #397.

Harbor Capital Advisors first reported a position in LMAT in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.28M in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Harbor Capital Advisors held 8,951 shares of LeMaitre Vascular worth $859K as of Q2 2026.
Harbor Capital Advisors sold 47 LeMaitre Vascular shares in Q2 2026, an estimated $4.82K.
LeMaitre Vascular made up 0.06% of Harbor Capital Advisors's portfolio in Q2 2026, its #397 holding.
Harbor Capital Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 11 quarters since.
Harbor Capital Advisors's LeMaitre Vascular position peaked at $2.28M in Q4 2024.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.